Beata Sawczuk | Dentistry | Best Researcher Award

Dr. Beata Sawczuk | Dentistry | Best Researcher Award

Medical University of Bialystok | Poland

Dr. Beata Sawczuk is a distinguished researcher in dental sciences and oral pathology, recognized for her significant contributions to understanding oral health, prosthetic rehabilitation, and oncological conditions of the oral cavity. With an h-index of 4, 9 scientific documents, and 63 citations , her work bridges clinical dentistry and biomedical research. Dr. Sawczuk’s research spans diverse areas, including oxidative stress markers in post-surgical cancer patients, the role of estrogen receptors in oral and vaginal mucosa, and the impact of oncogenic viruses in oral squamous cell carcinoma. Her publications in reputed journals such as Antioxidants, Pharmaceuticals, and International Journal of Molecular Sciences demonstrate an evidence-based approach to improving quality of life among patients with oral cavity cancers. A Fellow of the American Academy of Maxillofacial Prosthetics (AAMP) and the European Prosthodontic Association, she has also been a long-standing member of the Polish Dental Society and the Polish Chamber of Physicians and Dentists. Her professional interests include prosthetic rehabilitation after cancer surgery, analysis of oxidative stress biomarkers, and the development of innovative therapeutic approaches for oral tissue restoration. Through her multidisciplinary work, Dr. Sawczuk continues to advance prosthodontic science and patient-centered oral healthcare.

Profiles : Scopus | Orcid

Featured Publications

Sawczuk, B., Supruniuk, E., Żebrowska, E., Nayar, S., Chabowski, A., & Sierpińska, T. (2025). Evaluation of oxidative stress markers in post-surgical head and neck cancer patients rehabilitated with removable prosthetic restorations. Antioxidants, 14(11), 1285.

Czarnowski, M., Wnorowska, U., Łuckiewicz, M., Dargiewicz, E., Spałek, J., Okła, S., Sawczuk, B., Savage, P. B., Bucki, R., & Piktel, E. (2024). Natural antimicrobial peptides and their synthetic analogues for effective oral microflora control and oral infection treatment—The role of ceragenins in the development of new therapeutic methods. Pharmaceuticals, 17(12), 1725.

Karasiński, M., Wnorowska, U., Daniluk, T., Deptuła, P., Łuckiewicz, M., Paprocka, P., Durnaś, B., Skłodowski, K., Sawczuk, B., Savage, P. B., et al. (2024). Investigating the effectiveness of ceragenins against Acinetobacter baumannii to develop new antimicrobial and anti-adhesive strategies. International Journal of Molecular Sciences, 25(13), 7036.

Sawczuk, M., Sawczuk, B., Miąsko, A., & Szarmach, I. (2018). The role of oncogenic viruses in the etiopathogenesis of oral squamous cell carcinoma – Literature review. Protetyka Stomatologiczna, 68(2), 123–130.*

Sawczuk, M., Sawczuk, B., Miąsko, A., & Szarmach, I. (2017). Etiological factors in the formation of squamous cell carcinoma – Literature review. Journal of Stomatology, 70(4), 251–257.*

Sawczuk, B., Gołȩbiewska, M., Mazurek, A., & Chyczewski, L. (2017). Immunohistochemical evaluation of oestrogen receptors α and β in epithelium of the vaginal mucous membrane in women after oestrogen therapy. Przegląd Menopauzalny, 16(4), 171–177.*

Preferansow, E., Sawczuk, B., Gołębiewska, M., & Górska, M. (2015). Pathologies of the oral cavity in patients with non-controlled diabetes type 1 and type 2 – Analysis of periodontal status and periodontal treatment needs. Endokrynologia Polska, 66(5), 421–427.*

Sawczuk, B., Gołębiewska, M., Mazurek, A., & Chyczewski, L. (2014). Evaluation of estrogen receptor-β expression in the epithelium of the oral mucosa in menopausal women under hormone replacement therapy. Advances in Medical Sciences, 59(1), 90–95.*

 

Yash Brahmbhatt | Dentistry | Best Researcher Award

Mr. Yash Brahmbhatt | Dentistry | Best Researcher Award

Tufts University School of Dental Medicine | United States

Author Profile

Orcid

🎓 Early Academic Pursuits

Mr. Yash Brahmbhatt’s journey in education began with the International Baccalaureate® Career-related Programme at Atlantic High School, where he laid a solid foundation in health sciences and leadership. He pursued a Bachelor of Science in Public Health at Nova Southeastern University, complementing it with minors in Experiential Leadership and Pre-Health. His academic journey reached new heights when he enrolled in the Doctor of Medicine in Dentistry (DMD) program at Tufts University School of Dental Medicine (TUSDM), where he is on track to graduate in May 2027. His early focus on interdisciplinary learning and public service laid the groundwork for a multifaceted professional career.

💼 Professional Endeavors

Mr. Brahmbhatt has held diverse roles across academia, research, leadership, and community engagement. At Tufts, he is actively involved as a Teaching Assistant in multiple dental courses and serves as President of the AI in Dental Research & Education Society. His professional experiences extend to being Vice President of the Dental Entrepreneurship Club, an Admissions Ambassador, and a Researcher at Tufts Medical Center, where he investigates critical issues in dentistry and public health. His leadership roles within national organizations such as ASDA and ADEA highlight his growing influence in dental education and policy.

🧠 Contributions and Research Focus

Yash’s research contributions are wide-ranging and impactful. His work includes studies on peri-implant diseases, the link between periodontitis and cognitive decline, and AI applications in healthcare, including machine learning, language models, and 3D scanning technology. His dedication to innovation is further demonstrated through his leadership in organizing symposia and advancing evidence-based implant dentistry. He is especially passionate about integrating artificial intelligence into dental practice and education, setting a new standard for the next generation of practitioners.

🏆 Accolades and Recognition

Throughout his academic and professional journey, Mr. Brahmbhatt has earned numerous recognitions, such as membership in the President’s 64 at Nova Southeastern University, leadership appointments in national dental associations, and his role as CEO of the Saving Smile Foundation. His certification portfolio—from HIPAA to OSHA—reflects a deep commitment to ethical and safe practices in healthcare. His honors and positions speak to his integrity, ambition, and the trust he has garnered across institutions.

🌍 Impact and Influence

Mr. Brahmbhatt’s influence goes beyond clinical and academic excellence. As a mission and service trip veteran, he has contributed to healthcare access in Guatemala, India, and underserved communities in Florida. Through community efforts and his foundation, he champions oral health equity, youth engagement, and environmental advocacy via his Seize The Sea organization. His multilingual abilities and cross-cultural competencies enhance his impact in global and local communities alike.

✨ Legacy and Future Contributions

With a unique blend of clinical skill, research innovation, entrepreneurial mindset, and community spirit, Mr. Brahmbhatt is shaping the future of dentistry. His continued work in AI integration, public health policy, and dental education reform positions him as a changemaker. Looking ahead, he is poised to lead transformative efforts in improving oral healthcare systems, fostering interdisciplinary collaborations, and inspiring the next generation of dental leaders. His legacy is one of service, science, and sustained impact.

Publications


📄 Association Between Ethylene Oxide Exposure and Complete Edentulism in United States Adults

Authors: Yash Brahmbhatt, Michelle Zak, Razan Alhajri, Noura Almulla, Sakeenah Alqallaf, Abdullah Alkandari, Shahad Alsaleh, Hend Alqaderi
Journal: Life
Year: 2025


📄 Association Between Severe Periodontitis and Cognitive Decline in Older Adults

Authors: Yash Brahmbhatt, Hend Alqaderi, Zahra Chinipardaz
Journal: Life
Year: 2024


Bojan Miletic | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Bojan Miletic | Medicine and Dentistry | Best Researcher Award

University of Rijeka | Croatia

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 📚

Assoc. Prof. Dr. Bojan Miletic began his academic journey at the University of Rijeka, Croatia, where he studied medicine from 1986 to 1992. His early education laid a strong foundation for his diverse career in internal medicine, cardiology, and rehabilitation. After completing his medical degree, Dr. Miletic went on to specialize in internal medicine, cardiology, and geriatric rehabilitation through various educational institutions, including the Clinical Hospital Center Rijeka, the Lucerne Cantonal Hospital in Switzerland, and several other renowned centers across Europe. His rigorous training allowed him to acquire multiple certifications and broaden his expertise in interdisciplinary medicine.

Professional Endeavors 🏥

Dr. Miletic has a distinguished professional career, spanning over two decades in various hospitals and rehabilitation centers across Europe. He currently serves as an Associate Professor and Co-Head of the Department of Clinical Medical Sciences at the University of Rijeka, Croatia, where he engages in both student education and clinical research. Alongside his academic duties, he also works as a Specialist in Internal Medicine and Cardiology at Policlinic Primari in Rijeka and the General Hospital and Homeland War Veterans Hospital in Ogulin, Croatia. His work in clinical settings, including the establishment of new medical units, has contributed significantly to the field.

Throughout his career, Dr. Miletic held leadership roles at several prestigious institutions, including the Lucerne Cantonal Hospital in Switzerland, the Zurich Rehabilitation Center, and Herzpark Hardterwald in Germany. His roles ranged from Co-Head of Rehabilitation Centers to Head of Cardiac Rehabilitation Departments. He also contributed to the development of new rehabilitation centers, providing education and training to nurses, physiotherapists, and doctors.

Contributions and Research Focus 🔬

Dr. Miletic has made significant contributions to clinical research, particularly in the areas of geriatric rehabilitation, cardiology, and internal medicine. His work has addressed key health issues such as depression in the elderly, rehabilitation outcomes, and diagnostic challenges in internal medicine. Dr. Miletic’s research has resulted in numerous articles published in respected journals, such as Medicina, J Sport Rehabil, Lancet Oncol, and Int J Cardiol. His studies often focus on innovative treatment methods, diagnostic challenges, and interdisciplinary approaches to medicine, aiming to improve patient outcomes and healthcare practices across various specialties.

Accolades and Recognition 🏅

Dr. Miletic’s contributions to the medical field have not gone unnoticed. He has received several prestigious awards, including the Green Card for contributing to the development of a culture of respect and promotion of patients' rights by the Croatian Movement for the Patients' Rights. He has also been honored by the Croatian Medical Association for his merits in advancing the medical profession and his health and humanitarian efforts. His excellence in clinical research, education, and leadership has earned him recognition from various professional bodies.

Impact and Influence 🌍

With over 20 years of experience in clinical and academic settings, Dr. Miletic has profoundly impacted the fields of cardiology, internal medicine, and rehabilitation. His role in establishing new departments and hospitals has improved medical services and patient care. His international experience and collaborations across Europe have allowed him to influence healthcare practices and medical education in multiple countries. His ongoing participation in congresses, scientific activities, and as a member of numerous professional societies further amplifies his influence on the global medical community.

Legacy and Future Contributions 🔮

Dr. Miletic’s career is marked by his unwavering commitment to improving patient care, advancing medical research, and educating the next generation of healthcare professionals. His work in developing new rehabilitation centers and his leadership in clinical research will continue to shape the future of healthcare in Europe and beyond. As an active member of professional societies like the European Society of Cardiology and the European Society of Cardiovascular Imaging, Dr. Miletic is poised to make continued contributions to the medical field, ensuring that his legacy as a leader in cardiology, rehabilitation, and internal medicine endures for years to come.

Publications


  • 📄Depression and Its Effect on Geriatric Rehabilitation Outcomes in Switzerland’s Aging Population

      • Authors: Bojan Miletic, Antonia Plisic, Lejla Jelovica, Jan Saner, Marcus Hesse, Silvije Segulja, Udo Courteney, Gordana Starcevic-Klasan
      • Journal: Medicina
      • Year: 2025

  • 📄Icterus provoked by Echinococcus mimicking a tumor: A diagnostic challenge

      • Authors: Bojan Miletic, Yves Sutter, Elefteri Buset, Silvije Segulja, Marcus Hesse
      • Journal: Travel Medicine and Infectious Disease
      • Year: 2025

  • 📄The Physical Activity and Dietary Habits of Nursing Students

    • Authors: Željko Jovanović, Maja Šarić, Bojan Miletic
    • Journal: Medical Research Archives
    • Year: 2024

  • 📄Virtual reality in the education of instrumentation techniques for nurses/technicians

    • Authors: Marija Spevan, Željko Jovanović, Bojan Miletic
    • Journal: World of Health
    • Year: 2024

  • 📄Infarkt miokarda s elevacijom ST segmenta kao indikacija za hitan medicinski transport u Opću bolnicu Zadar

    • Authors: Slavica Balgavi, Silvije Šegulja, Bojan Miletic
    • Event: 27th Congress of Emergency Medicine with International Participation
    • Year: 2024

 

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

 

Publications


📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

  • Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
  • Journal: Nutrients
  • Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

  • Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2024

📄  Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

  • Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
  • Journal: Drugs in R and D
  • Year: 2024

📄  Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

  • Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
  • Journal: PharmacoEconomics
  • Year: 2023

📄  Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

  • Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
  • Journal: Diseases of the Colon and Rectum
  • Year: 2022

 

Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Assist Prof Dr. Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Rambam Health Care Campus | Israel

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Shadi Hamoud's academic journey began with the completion of his MD (cum laude) from the Faculty of Medicine at the Hebrew University, Jerusalem, in 1995. His commitment to medical excellence was evident from the beginning, as he specialized in Internal Medicine during his residency at Rambam Medical Center from 1996 to 2002. His passion for teaching also emerged early, as he served as a tutor and lecturer for medical students and advanced nursing courses at Rambam Health Care Campus.

Professional Endeavors 🏥

Dr. Hamoud has held several key roles throughout his career. Since 2010, he has been the Director of the Clinical Research Unit at the Internal Medicine E Department, Rambam Medical Center. He also serves as the Deputy Director of the same department. His expertise is sought by major pharmaceutical companies such as Bayer and Pfizer, where he has been a medical consultant since 2016 and 2017, respectively. Additionally, Dr. Hamoud plays a vital role on various medical committees, including the committee for blood product transfusions at Rambam and the specialty committee within the hospital.

Contributions and Research Focus 🔬

Dr. Hamoud's research interests are broad, focusing on critical issues in cardiovascular medicine, diabetes, and novel COVID-19 treatments. He has investigated lipoprotein oxidation and atherosclerosis, as well as the enzyme heparanase and its impact on kidney injuries, fatty liver disease, and other conditions. His involvement in international clinical trials and research on lipid-modifying drugs and new oral anticoagulants highlights his commitment to advancing medical science.

Accolades and Recognition 🏅

Dr. Hamoud has received numerous awards throughout his career, recognizing his dedication to both medicine and education. Between 2003 and 2016, he was named an Excellent Lecturer by the Internal Medicine E Department at Rambam Health Care Campus. In 2008, he was also honored with an Excellence in Medicine award, further cementing his reputation as a distinguished medical professional.

Impact and Influence 🌍

Dr. Hamoud’s influence extends beyond academia and clinical practice. He has been actively involved in public health education, delivering lectures at local schools in his hometown of Majd Al-Kurum. His role as an examiner in Israel’s internal medicine specialization exams underscores his commitment to shaping the next generation of medical professionals. He has also contributed to the medical field through his membership in professional societies, including the European Society of Hypertension and the Israeli Society of Hypertension.

Legacy and Future Contributions 🌱

Dr. Hamoud's work in medical research, clinical practice, and education has left a lasting impact on the healthcare field in Israel and beyond. His ongoing roles in clinical research, his contributions to new therapies for chronic diseases, and his mentorship of future doctors ensure that his influence will continue to grow. As a leader in both medicine and research, his legacy is one of commitment to improving health outcomes and advancing scientific knowledge for the benefit of future generations

 

Publications


  • 📄"Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury" 🐭
    Authors: Heba Abd Alkhaleq, Shadi Hamoud, Israel Hacker, Tony Karram, Ahmad Fokra, Aviva Kabala, Zaid Abassi
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄"Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure" 🐀
    Authors: Ravit Cohen-Segev, Omri Nativ, Safa Kinaneh, Doron Aronson, Aviva Kabala, Shadi Hamoud, Tony Karram, Zaid Abassi
    Journal: International Journal of Molecular Sciences
    Year: 2023

  • 📄"Heparanase Inhibition Prevents Liver Steatosis in E₀ Mice" 🧬
    Authors: Safa Kinaneh, Walaa Hijaze, Lana Mansour-Wattad, Rawan Hammoud, Hisam Zaidani, Aviva Kabala, Shadi Hamoud
    Journal: Journal of Clinical Medicine
    Year: 2022

 

Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

Dr. Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

University of Chieti | Italy

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Ylenia Della Rocca’s academic journey began with exceptional achievements in biotechnology. In 2018, she earned her degree in Biotechnology with a perfect score of 110/110 cum laude from the University of L'Aquila. Her thesis, centered on "Hairy Cell Leukemia," set the stage for her future in oncohematological genetics. She continued to excel with a Master’s degree in Medical Biotechnology, again graduating with academic praise. Her research on the HLA-G 3' UTR region in kidney transplantation at the National Research Center solidified her expertise in medical biotechnology.

🏥 Professional Endeavors

Currently, Dr. Della Rocca serves as a Researcher Technologist and Subject Expert in Histology and Embryology at the University of Chieti. Her impressive academic trajectory culminated in a Ph.D. in "Innovative Technologies in Clinical Medicine & Dentistry" in 2024. As part of her doctoral research, she developed a new iPS cell line during her tenure at the University of Barcelona and Josep Carreras Leukaemia Research Institute. Beyond her role as a researcher, Dr. Della Rocca has been a prominent speaker at numerous international conferences, where her work has garnered significant recognition.

🔬 Contributions and Research Focus

Dr. Della Rocca’s research is at the forefront of biotechnology and regenerative medicine. Her completed and ongoing projects include the development of three-dimensional disease models, studies on tissue differentiation, and the establishment of new iPS cell lines. She has also been pivotal in creating innovative models for carcinogenesis research. Her current patent under review—"Pluripotent Stem Cells Induced by Autologous Gingival Stem Cells and Extracellular Vesicles: A Novel Approach for Cardiac Regeneration"—underscores her groundbreaking contributions to stem cell therapies and regenerative medicine.

🏆 Accolades and Recognition

Dr. Della Rocca’s research career has been marked by numerous accolades, including two prestigious awards for her scientific achievements. She has been a Guest Editor for special issues in renowned journals like the International Journal of Molecular Sciences and has served as a Review Editor for Frontiers in Genetics and Frontiers in Cell and Developmental Biology. Her citation index of 10 reflects the growing impact of her research in the scientific community.

🌍 Impact and Influence

Dr. Della Rocca’s work transcends academic research, as evidenced by her collaborations with top universities and research institutes worldwide, including the University of Barcelona, IRCCS Sicily, and the University of Montreal. She is an active member of the Italian Society of Anatomy and Histology and the Sigma Xi Scientific Research Honor Society. Dr. Della Rocca’s commitment to healthcare is further exemplified by her founding of Associazione Sorrisi in Ospedale (A.S.I.O.), a third-sector organization aimed at improving patient care in hospitals.

🔮 Legacy and Future Contributions

As a leader in the fields of stem cells, bioengineering, and regenerative medicine, Dr. Ylenia Della Rocca continues to push the boundaries of scientific knowledge. Her contributions to cell-free therapies and the development of three-dimensional models hold immense promise for future medical applications. With her ongoing work in stem cell regeneration and epigenetic research, Dr. Della Rocca is poised to shape the next frontier of clinical and research tools, leaving a lasting legacy in biotechnology.

 

Publications


📄 Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration
Authors: Ylenia Della Rocca, Francesca Diomede, Fanì Konstantinidou, Valentina Gatta, Liborio Stuppia, Umberto Benedetto, Marco Zimarino, Paola Lanuti, Oriana Trubiani, Jacopo Pizzicannella
Journal: International Journal of Molecular Sciences
Year: 2024


📄 Biological Effects of PMMA and Composite Resins on Human Gingival Fibroblasts: An In Vitro Comparative Study
Authors: Ylenia Della Rocca, Enrico Matteo Traini, Oriana Trubiani, Tonino Traini, Antonella Mazzone, Guya Diletta Marconi, Jacopo Pizzicannella, Francesca Diomede
Journal: International Journal of Molecular Sciences
Year: 2024


 

Ahmed Alzahrani | Dentistry | Best Researcher Award

Dr. Ahmed Alzahrani | Dentistry | Best Researcher Award

King Abdulaziz University | Saudi Arabia

Author Profile

Google Scholar

🏅 Early Academic Pursuits

Dr. Ahmed Alzahrani's journey into pediatric dentistry began with his pursuit of a Bachelor’s degree in Dental Medicine and Surgery at King Abdulaziz University, graduating in June 2013. His academic excellence was evident early on, achieving a remarkable GPA of 4.2. His passion for learning and commitment to pediatric dentistry led him to further his studies, culminating in a Master’s degree in Dental Science in Pediatric Dentistry from the same university, where he excelled with a GPA of 4.7. This strong academic foundation set the stage for his future contributions to the field.

👨‍⚕️ Professional Endeavors

Dr. Alzahrani's professional career is marked by his dedication to pediatric dentistry. He began as a General Dentist at the Ministry of Health in Taif, where he served from February 2013 to March 2016. His commitment to pediatric care led him to specialize in pediatric dentistry, taking on roles as a Pediatric Dentistry Resident and later as a Specialist at the King Abdulaziz University and a specialized dental center in Taif. His expertise and passion for teaching were evident as he supervised undergraduate students in pediatric dentistry clinics at King Abdulaziz University, shaping the next generation of dentists.

🔬 Contributions and Research Focus

Dr. Alzahrani's research is deeply rooted in advancing pediatric dental care. His PhD research at King Abdulaziz University focuses on innovative approaches in pediatric dentistry, including the use of advanced diagnostic tools and materials. His work on the tomographic evaluation of internal adaptation for calcium silicate-based pulp capping materials in primary teeth and his exploration of salivary OMICs for understanding oral and medical diseases have contributed significantly to the field. His passion for research is reflected in his numerous publications, poster presentations, and lectures, where he shares his findings and insights with the broader dental community.

🏆 Accolades and Recognition

Dr. Alzahrani's contributions have not gone unnoticed. He has been recognized with several awards, including 2nd place in the IADR Saudi Division Unilever Hatton Competition at the International Dental Meeting in 2019. His excellence in pediatric dentistry also earned him a Certificate of Excellence from the Director of Health Affairs in Taif in 2016. These accolades underscore his commitment to excellence in both clinical practice and research.

🌟 Impact and Influence

Dr. Alzahrani's impact extends beyond his immediate clinical work. His participation in various conferences, including the organization of the 11th International Conference of KAU, reflects his influence in the academic and professional community. His interest in artificial intelligence, deep learning, and genetic studies indicates his forward-thinking approach, which has the potential to revolutionize pediatric dentistry. Through his teaching, research, and clinical practice, Dr. Alzahrani continues to shape the future of pediatric dentistry, inspiring both his peers and students.

🚀 Legacy and Future Contributions

As Dr. Alzahrani continues his PhD studies and professional endeavors, his future contributions to pediatric dentistry are poised to be groundbreaking. His research interests in AI, deep learning, and microbiome studies suggest that he will be at the forefront of integrating technology with dental care. His dedication to education and research ensures that his legacy will be one of innovation, excellence, and a lasting impact on the field of pediatric dentistry.

 

Publications


  • 📄Tomographic Evaluation of the Internal Adaptation for Recent Calcium Silicate‐Based Pulp Capping Materials in Primary Teeth
    Authors: AA Al Tuwirqi, EA El Ashiry, AY Alzahrani, N Bamashmous, TA Bakhsh
    Journal: BioMed Research International
    Year: 2021

  • 📄 Contemporary Understanding of the Etiology and Management of Molar Incisor Hypomineralization: A Literature Review
    Authors: AY Alzahrani, NMH Alamoudi, OAES El Meligy
    Journal: Dentistry Journal
    Year: 2023

  • 📄 The Influence of Parental Oral Health Literacy on Children's Oral Health: A Scoping Review
    Authors: AY Alzahrani, O El Meligy, D Bahdila, R Aljawi, NO Bamashmous, ...
    Journal: Journal of Clinical Pediatric Dentistry
    Year: 2024

  • 📄 Health and Oral Health Literacy: A Comprehensive Literature Review from Theory to Practice
    Authors: AY Alzahrani, O El Meligy, D Bahdila, R Aljawi, NO Bamashmous, ...
    Journal: International Journal of Paediatric Dentistry
    Year: 2024

  • 📄 The Potential Use of Salivary OMICs in Understanding the Pathogenesis and Diagnosis of Oral and Medical Diseases
    Authors: AY Alzahrani, DA Alblaihed, DY Jamal, ST Ibrahim, GMA Ajabnoor, ...
    Journal: Journal of Microscopy and Ultrastructure
    Year: 2023

 

Kumaresan Sakthiabirami | Dentistry | Best Researcher Award

Dr. Kumaresan Sakthiabirami | Dentistry | Best Researcher Award 

Chonnam National University | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Kumaresan Sakthiabirami's academic journey in dentistry began with a Bachelor of Dental Surgery (BDS) degree from Rajah Muthiah Dental College and Hospital, Annamalai University, India. Following this, she pursued advanced studies in prosthodontics at Chonnam National University, South Korea, earning a Master's degree in February 2018 and a PhD in August 2020. Her doctoral research focused on implant surface modifications and bone tissue engineering, laying a strong foundation for her future endeavors.

Professional Endeavors

Dr. Sakthiabirami has amassed significant experience in both research and clinical practice. She has worked as a Research Professor at the Biomedical Evaluation and Research Centre, School of Dentistry, Chonnam National University, from May 2022 to July 2023. Prior to this role, she was a Post-Doctoral Research Fellow at the same institution, engaging in cutting-edge research in biomaterials and 3D bioceramic printing. Additionally, she has held positions as a Research Fellow in the Department of Prosthodontics and as an Associate Dental Practitioner in India.

Contributions and Research Focus

Dr. Sakthiabirami's research has been pivotal in the fields of biomaterial development and bone tissue engineering. She has contributed to the development of bone-mimicking 3D porous hybrid zirconia scaffolds and high-strength zirconia for additive manufacturing processes. Her work on implant surface modifications and hydrogels for bone tissue engineering has been widely recognized, and she has published numerous papers on these topics. Her technical expertise includes material synthesis, characterization techniques, and fabrication methods, positioning her as a leader in dental biomaterials research.

Accolades and Recognition

Throughout her career, Dr. Sakthiabirami has received several honors and awards. Notably, she won the Excellence Poster Award from the Korean Academy of Stomatognathic Function and Occlusion in 2019 for her work on argon plasma treatment on titanium surfaces. She has also actively participated in international conferences and seminars, presenting her research at prestigious events such as the International Symposium on Surfaces and Interfaces for Biomaterials and the International Association for Dental Research (IADR).

Impact and Influence

Dr. Sakthiabirami's work has significantly impacted the field of dental research, particularly in implant dentistry and biomaterials. Her innovative approaches to 3D printing and surface modifications have enhanced the development of more effective and durable dental implants and prostheses. Her research has not only advanced academic knowledge but has also contributed to practical applications in clinical dentistry, improving patient outcomes and advancing the field of dental materials.

Legacy and Future Contributions

Looking ahead, Dr. Sakthiabirami's legacy in dental research and practice continues to grow. Her ongoing projects and collaborations are expected to yield further advancements in biomaterials and bone tissue engineering. Her commitment to integrating cutting-edge technology with clinical applications positions her to continue making significant contributions to dental science and education. As she progresses in her career, Dr. Sakthiabirami will undoubtedly remain a key figure in the ongoing evolution of dental research and technology.

 

Notable Publications

Manganese ion batteries: LiV3O8 nanorods as a robust and long-life cathode module 2023 (2)

The Impact of Particle Size and Surface Treatment of Zirconia Suspension for Photocuring Additive Manufacturing 2023 (3)

Effects of UV Absorber on Zirconia Fabricated with Digital Light Processing Additive Manufacturing 2022 (6)

Evaluation of Physical Properties of Zirconia Suspension with Added Silane Coupling Agent for Additive Manufacturing Processes 2022 (12)

Closer to nature: Recreating extracellular matrix microenvironment with 3D printing 2024

 

 

 

Linmang Qin | Medicine and Dentistry | Best Researcher Award

Prof. Linmang Qin | Medicine and Dentistry | Best Researcher Award

Guangdong Provincial People's Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Lin Mang Qin pursued a Bachelor's degree in Clinical Medicine from Jiujiang University, where he ranked in the top 1% based on comprehensive assessments. He continued his academic journey by completing a Master's degree in Clinical Medicine at South China University of Technology, earning first-class academic scholarships each year during his master's studies.

Professional Endeavors

Currently serving as a Scientific Research Assistant at Guangdong Provincial People’s Hospital since August 2022, Prof. Qin has been deeply involved in theoretical studies, clinical work, and scientific research over the past four years. His responsibilities include conducting basic scientific research at the hospital's public experimental platform and supervising scientific research experiments.

Contributions and Research Focus

Prof. Qin has contributed significantly to the field of clinical medicine, particularly in areas related to autoimmune diseases and gene expression analysis. His research focuses on topics such as fibroblast mesenchymal transition in systemic sclerosis-associated interstitial lung disease (SSc-ILD) and gene expression profiling in polymyositis.

Accolades and Recognition

Prof. Qin's research has garnered international recognition, with publications in prestigious journals such as "iScience" and "Heliyon." Notably, his work has been nominated for the Best Researcher Award, and his methods have been praised by journals for their potential impact on the scientific community.

Impact and Influence

Prof. Qin's research has contributed to advancing our understanding of autoimmune diseases and gene expression regulation, potentially paving the way for novel therapeutic interventions. His involvement in national natural science projects and collaborations with esteemed institutions reflect his impactful contributions to the scientific community.

Legacy and Future Contributions

As the team leader of the public experimental platform at Guangdong Provincial People's Hospital, Prof. Qin continues to mentor and train aspiring researchers while actively engaging in cutting-edge scientific research. His proficiency in various scientific research techniques and dedication to advancing medical knowledge position him as a leader in the field, with a promising future marked by continued innovation and discovery.

Notable Publications

CD4+LAG3+T cells are decreased in SSc-ILD and affect fibroblast mesenchymal transition by TGF-β3 2023

Screening and validation of differentially expressed genes in polymyositis 2024

 

 

Ao Gu | Medicine and Dentistry | Best Researcher Award

Dr. Ao Gu | Medicine and Dentistry | Best Researcher Award

Shanghai Jiao Tong University School of Medicine | China

Author profile

Scopus

Early Academic Pursuits

Dr. Ao Gu completed his M.B in Clinical Medicine at Hebei University Health Science Center and is pursuing a master's degree at Shanghai Jiao Tong University School of Medicine, focusing on antitumor-active molecules under Prof. Yingbin Liu's mentorship.

Professional Endeavors

With a background in Clinical Medicine, Dr. Gu's professional journey includes extensive research in therapeutic molecules. He actively contributes to the scientific community through his publications and ongoing academic pursuits.

Contributions and Research Focus

Dr. Gu's research primarily centers on exploring the therapeutic capabilities of antitumor-active molecules. His work spans various aspects of medicine and chemistry, ranging from patient-derived models to single-cell omics analysis.

Accolades and Recognition

Dr. Ao Gu has gained recognition for his significant contributions to the field, as evidenced by his publications in reputable scientific journals. His work has been acknowledged for its innovation and potential impact on cancer research.

Impact and Influence

Through his research, Dr. Gu has the potential to influence advancements in cancer treatment and therapeutic molecule development. His contributions add valuable insights to the scientific community's understanding of antitumor agents.

Legacy and Future Contributions

Dr. Ao Gu's legacy lies in his dedication to advancing medical knowledge and developing novel therapeutic approaches. His future contributions are anticipated to further enrich the field of oncology and inspire aspiring researchers in the pursuit of medical excellence.

Notable Publications

Six-Membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications 2023

Aggregation-enabled alkene insertion into carbon–halogen bonds 2023 (1)

Solvent-free and Catalyst-free Direct Alkylation of Alkenes 2023 (1)

Trisubstituted alkenes featuring aryl groups: stereoselective synthetic strategies and applications 2023 (3)